ALMED Medicrea International SA Class O

Medicrea to Participate in the Canaccord Genuity Musculoskeletal Conference and Present Clinical Results at AAOS 2018

LYON, France & NEW YORK--(BUSINESS WIRE)--

The Medicrea Group (Euronext Growth Paris: FR0004178572 - ALMED), pioneering the convergence of healthcare IT and next-generation, outcome-centered spinal device design and manufacturing with UNiD ASI™ (Adaptive Spine Intelligence) technology, announced today that the Company will present at the Canaccord Genuity Musculoskeletal Conference on Tuesday, March 6, 2018 at 11:30 a.m. CT (6:30 p.m. GMT+1) at the Sheraton New Orleans Hotel in New Orleans, LA.

Clinical results on the Company’s patient-specific UNiD™ Rod will be presented by Dr. Andrew King at the Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS). The podium, entitled “Radiographic Comparison of Patient-Specific and Manually Contoured Conventional Rods in Adolescent Idiopathic Scoliosis Surgery”, will take place in the session beginning at 11:00 a.m. CT (6:00 p.m. GMT+1) held in Room 345 of the Morial Convention Center on Friday, March 9th.

About Medicrea (www.medicrea.com)

Through the lens of predictive medicine, Medicrea leads the design, integrated manufacture, and distribution of 30+ FDA approved spinal implant technologies that have been utilized in over 150,000 spinal surgeries to date. By leveraging its proprietary software analysis tools with big data and machine learning technologies and supported by an expansive collection of clinical and scientific data, Medicrea is well-placed to streamline the efficiency of spinal care, reduce procedural complications and limit time spent in the operating room.

Operating in a $10 billion marketplace, Medicrea is a Small and Medium sized Enterprise (SME) with 175 employees worldwide, which includes 50 who are based in the U.S. The Company has an ultra-modern manufacturing facility in Lyon, France housing the development and production of 3D-printed titanium patient-specific implants.

For further information, please visit: Medicrea.com.

Connect with Medicrea:

FACEBOOK | INSTAGRAM | TWITTER | WEBSITE | YOUTUBE

Medicrea is listed on

EURONEXT Growth Paris

ISIN: FR 0004178572

Ticker: ALMED

LEI: 969500BR1CPTYMTJBA37

EN
05/03/2018

Underlying

ALMEDMedicrea International SA Class O

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Medicrea International SA Class O

 PRESS RELEASE
Free
ALMED Medicrea Intern...

MEDICREA Reports Third Quarter 2020 Sales

LYON, France & NEW YORK--(BUSINESS WIRE)-- The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, publishes sales for the third quarter of 2020. (€ millions) YTD September 2019 YTD September 2020 Variation USA Rest of the world Total Sales Including Q3 13.7 10.6 24.3 8.2 12.6 8.7 21....

October 8, 2020 1 EN
 PRESS RELEASE
Free
ALMED Medicrea Intern...

MEDICREA Reports First Half 2020 Results

LYON, France & NEW YORK--(BUSINESS WIRE)-- The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, reports its unaudited results for the first half of 2020, as approved by the Board of Directors on August 28, 2020. €’million Q1 2020 Q2 2020 H1 2020 H1 2019 Sales Gross margin in % of sales EBITDA (1...

September 4, 2020 1 EN
 PRESS RELEASE
Free
ALMED Medicrea Intern...

MEDICREA Announces the Appointment of an Independent Expert

LYON, France & NEW YORK--(BUSINESS WIRE)-- The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, announces the appointment of an independent expert. Following the announcement of the voluntary and friendly cash tender offer for the shares of Medicrea International (Euronext Growth Paris: FR0004178572 - ALMED, PEA-PME e...

August 3, 2020 1 EN
 PRESS RELEASE
Free
ALMED Medicrea Intern...

Medtronic to Acquire Medicrea

DUBLIN & LYON, France--(BUSINESS WIRE)-- Medtronic plc (NYSE:MDT), a global leader in medical technology, and Medicrea (Euronext Growth Paris: FR0004178572 – ALMED Medicrea; OTCQX Best Market – MRNTF), a pioneer in the transformation of spinal surgery through artificial intelligence, predictive modeling and patient specific implants, today announced that they have entered into a tender offer agreement for the acquisition of all outstanding shares of Medicrea. The friendly voluntary all-cash tender offer will be at a price of €7.00 per Medicrea share (the “Tender Offer”). The Boards of Director...

July 15, 2020 1 EN
 PRESS RELEASE
Free
ALMED Medicrea Intern...

MEDICREA Reports First Half 2020 Sales

LYON, France & NEW YORK--(BUSINESS WIRE)-- The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, publishes sales for the first half of 2020. (€ millions) H1 2019 H1 2020 Variation Variation at Constant Exchange Rate USA Rest of the world Total Sales 8.7 7.4 16.1 7.6 5.6 13.2 -13%...

July 9, 2020 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch